Vaxcyte's Dhaliwal exercises options, sells 17K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vaxcyte, Inc. Chief Technical Ops Officer Harpreet S. Dhaliwal exercised options for 17,000 common shares at $24.79 per share on November 11, 2026, then sold 17,000 shares in three transactions under a Rule 10b5-1 trading plan adopted April 6, 2026. Reported weighted-average sale prices were $67.33 for 7,135 shares, $68.156 for 9,345 shares and $68.819 for 520 shares; the option position after exercise was 11,000 shares.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F6 | 17,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 17,000 | $24.79 | $421K |
| Sale | Common Stock F1, F2 | 7,135 | $67.33 | $480K |
| Sale | Common Stock F1, F3 | 9,345 | $68.156 | $637K |
| Sale | Common Stock F1, F4, F5 | 520 | $68.819 | $36K |
Footnotes (6)
- F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026.
- F2. The price reported is a weighted-average price. The shares were sold at prices ranging from $66.76 to $67.755. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3. The price reported is a weighted-average price. The shares were sold at prices ranging from $67.76 to $68.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4. The price reported is a weighted-average price. The shares were sold at prices ranging from $68.76 to $68.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated October 6, 2026 were sold by the Reporting Person.
- F6. Stock Option is fully vested and exercisable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted-average price financial
fully vested and exercisable technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the terms of Harpreet S. Dhaliwal’s PCVX option exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.